CoronaVac, COVID-19 vaccine produced by China's Sinovac, approved for use in Nepal
Permission has been granted for use of CoronaVac, a Chinese COVID-19 vaccine, manufactured by Sinovac life sciences company limited, in Nepal.
The Department of Drug Administration (DDA) granted the approval for the use of the vaccine today.
KATHMANDU, November 22: The government has started providing COVID-19 vaccine to all people above 18 years of age. Prior to this, the vaccination campaign was focused on the target groups, but now it is available for al.
Joint Spokesperson at the Ministry of Health and Population, Dr Samir Kumar Adhikari said the government has decided to provide vaccines to all above 18 as the supplies are regular.
He urged all the eligible people who were missed in the previous vaccination campaigns to visit the nearby vaccinations centers and get the shot. The government has a target of vaccinating one-third of the population by coming mid-January and 21.07 million by coming mid-April.
To date, 30 percent of the total population has been given the first dose of vaccine while the population receiving the full-course is 26 percent. Kathmandu District Health Office Chief Shambhu Kafley said the vaccine is available at five centers: Birendra Military Hospital, Nepal police Hospital, Shahid Memorial Hospital, Kalanki; Bayodha Hospital, Balkhu; at Lhotse Building in New Buspark, Gongabu; and the Herbs Processing Center, Jadibuti in Kathmandu. ---
KATHMANDU, August 21: Over 4.8 million people were inoculated with the COVID-19 vaccines since President of Nepali Congress, Sher Bahadur Deuba became the Prime Minister of Nepal, according to the Ministry of Health and Population.
As of Thursday, as many as 4,811,733 people have received COVID-19 vaccine in the country since the takeover of the government by PM Deuba.
Prior to this as many as 3.6 million people were vaccinated against COVID-19. With this, the number of people receiving the vaccines against COVID-19 has reached 8,520,421, according to the health ministry. Nepal is currently administering COVID-19 vaccine to 150,000 people in a day on average.
Of 8,520,421 people, 494,523 have received their both doses of COVID-19 vaccine which accounts for 13 percent of the total population of the country. While 16.8 percent of the total population have received their first dose of COVID-19 vaccine. Before Deuba's tenure, only 3.9 percent of the population had received both doses of COVID-19 vaccine while the percent of people receiving their second doses was 9.1 percent.
The number of people receiving COVID-19 vaccines has almost doubled in the past five weeks. The government has projected to administer COVID-19 vaccine to 33 percent of the total population by mid-October and vaccinate all the eligible population by mid-April next year.
Japanese-made AstraZeneca COVID-19 vaccine arrived in Kathmandu
KATHMANDU, Aug 7: The Japanese-made AstraZeneca COVID-19 vaccine arrived in Kathmandu on Saturday.
Ambassador of Japan to Nepal, Kikuta Yutaka attended the hand-over ceremony at the Tribhuvan International Airport with State Minister of Health and Population Umesh Shrestha, Joint Secretary of North East Asia Division, Ministry of Foreign Affairs, Lok Bahadur Thapa, Representative of UNICEF Nepal, Elke Wisch and WHO Representative to Nepal, Dr Rajesh Sambhajirao Pandav.
This vaccine donation from Japan for Nepal through the COVAX facility was announced by Motegi Toshimitsu, Minister for Foreign Affairs of Japan on 13 July. Remaining half of 1.6 million doses pledged by Japan will be shipped to Kathmandu shortly,according to the Embassy of Japan in Nepal.
